SolGel Technologies Ltd. (SLGL) Reports Q1 Loss, Misses Revenue EstimatesZacks Investment Research • 05/13/22
Sol-Gel Technologies Reports First Quarter 2022 Financial Results and Provides Corporate UpdateGlobeNewsWire • 05/13/22
Earnings Preview: SolGel Technologies Ltd. (SLGL) Q1 Earnings Expected to DeclineZacks Investment Research • 05/05/22
Sol-Gel Technologies Reports Full Year 2021 Financial Results and Corporate DevelopmentsGlobeNewsWire • 03/30/22
Sol-Gel Technologies Announces U.S. Commercial Partner Galderma to Promote TWYNEO® at the American Academy of Dermatology Annual Meeting to be Held March 25-29 in Boston, MAGlobeNewsWire • 03/25/22
Sol-Gel Technologies to Participate in Upcoming LifeSci Partners Corporate Access Event and H.C. Wainwright BioConnect 2022 Healthcare ConferenceGlobeNewsWire • 12/22/21
Sol-Gel Technologies Announces Positive Update Related to FDA Review Status of EPSOLAY®GlobeNewsWire • 12/21/21
Sol-Gel Technologies Reports Third Quarter 2021 Financial Results and Highlights Recent Corporate DevelopmentsGlobeNewsWire • 11/11/21
Sol-Gel Technologies to Present Live at Jefferies London Healthcare ConferenceGlobeNewsWire • 11/09/21
SolGel Technologies Ltd. (SLGL) Earnings Expected to Grow: Should You Buy?Zacks Investment Research • 11/04/21
Sol-Gel Technologies to Present at Upcoming Cantor Virtual Global Healthcare ConferenceGlobeNewsWire • 09/22/21
Sol-Gel Technologies to Present at Upcoming H.C. Wainwright Global Investment ConferenceGlobeNewsWire • 09/09/21
Sol-Gel Technologies Reports Second Quarter 2021 Financial Results and Highlights Recent Corporate DevelopmentsGlobeNewsWire • 08/04/21
SolGel Technologies Ltd. (SLGL) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 ReleaseZacks Investment Research • 07/28/21
Sol-Gel Wins FDA Approval For Fixed-Dose Combination Of Tretinoin, Benzoyl Peroxide For Acne VulgarisBenzinga • 07/27/21
Sol-Gel Technologies to Report Second Quarter 2021 Financial Results on August 4th, 2021GlobeNewsWire • 07/20/21
Sol-Gel Technologies and Galderma Announce Exclusive Licenses for the Commercialization of EPSOLAY® and TWYNEO® in the United StatesBusiness Wire • 06/28/21
Sol-Gel Technologies Reports First Quarter 2021 Financial Results and Corporate UpdateGlobeNewsWire • 05/13/21
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Sol-Gel Technologies Ltd. - SLGLPRNewsWire • 04/28/21